 COPENHAGEN, Denmark, Feb. 18, 2021 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransConTM technologies to create product candidates that address unmet medical needs, today announced that the company will participate at the SVB Leerink 10th Annual Global Healthcare Conference. Company executives will provide a business overview and update on the companys pipeline programs. 